Form 4 for CL Colgate-Palmolive
Accepted 2024-02-15 00:00:00 ET · period of report 2024-02-13 · accession 0001225208-24-002144 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-15 | 2024-02-13 | CL | Edwards Lisa | Dir | M - OptEx | $69.38 | +2,078 | 11.8K | +21% | +$144.2K |
| D | 2024-02-15 | 2024-02-13 | CL | Edwards Lisa | Dir | M - OptEx | $0.00 | -2,078 | 2,077 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-13 | M | A | 2,078 | $69.38 | 11,805 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-02-13 | M | D | 2,078 | $0.00 | 2,077 | D | $69.38 · — to 2028-05-11 | 2,078 Common Stock | (F2) The original Form reporting this stock option grant inadvertently reflected the exercise price of the stock option as $69.83 instead of $69.38. (F3) Option became exercisable in one-third increments beginning on the first anniversary of the May 11, 2020 grant date. |